The Malaria Atlas Project has received a $16 million grant from the Bill & Melinda Gates Foundation to track and tackle malaria globally. The project will focus on boosting research in Sub-Saharan Africa, where malaria is endemic, and strengthening research capacity.
A clinical trial found that interferon can help reduce the spread of COVID-19 from a positive person to their household contacts. The study tracked 1,172 participants and showed that interferon treatment reduced viral load in households with high viral loads. However, it did not reduce disease severity.
Researchers have uncovered a new mechanism of antibiotic resistance in Group A Streptococcus bacteria, making antibiotics ineffective and potentially leading to poor outcomes. The discovery highlights the complexity of understanding AMR and emphasizes the need for rapid diagnostic tools and therapeutics.
A global consortium has launched best practice surveillance protocols for Group A Streptococcus (Strep A) research, providing clear case definitions and guiding researchers in clinical trials. The new protocols aim to accelerate the development of a safe and effective Strep A vaccine.
A parent-led therapy for early signs of autism has significantly reduced the likelihood of an autism diagnosis at age three. The iBASIS-VIPP program uses video-feedback to support social development and unique abilities, resulting in increased parental sensitivity and language development.
Researchers have developed a fine-scale malaria risk map to help public health experts target interventions in Haiti. The map uses data from satellite images, health facilities, and hand-written medical logs to identify areas at high risk of infection.